{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:00:54Z","timestamp":1791176454033,"version":"4.1.0"},"reference-count":240,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.pharmthera.2012.07.008","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T15:25:34Z","timestamp":1342797934000},"page":"94-105","source":"Crossref","is-referenced-by-count":136,"title":["Low-density lipoprotein receptor-related protein 1: A physiological A\u03b2 homeostatic mechanism with multiple therapeutic opportunities"],"prefix":"10.1016","volume":"136","author":[{"given":"Abhay P.","family":"Sagare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Deane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berislav V.","family":"Zlokovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2012.07.008_bb0005","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1523\/JNEUROSCI.0496-05.2005","article-title":"Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease","volume":"25","author":"Adlard","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0010","doi-asserted-by":"crossref","first-page":"876","DOI":"10.4065\/mcp.2011.0252","article-title":"Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging","volume":"86","author":"Ahlskog","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0015","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2353\/ajpath.2006.051107","article-title":"Reduction of amyloid angiopathy and Abeta plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways","volume":"169","author":"Ambree","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0169-328X(02)00203-6","article-title":"LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes","volume":"104","author":"Arelin","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.neurobiolaging.2009.03.016","article-title":"Chronic green tea consumption prevents age-related changes in rat hippocampal formation","volume":"32","author":"Assuncao","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10611860290031831","article-title":"Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy","volume":"10","author":"Bading","year":"2002","journal-title":"J Drug Target"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archneurol.2009.307","article-title":"Effects of aerobic exercise on mild cognitive impairment: a controlled trial","volume":"67","author":"Baker","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0040","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ymthe.2006.05.005","article-title":"Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC","volume":"14","author":"Bankiewicz","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0306-4522(03)00474-3","article-title":"Efflux of human and mouse amyloid beta proteins 1\u201340 and 1\u201342 from brain: impairment in a mouse model of Alzheimer's disease","volume":"121","author":"Banks","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0050","doi-asserted-by":"crossref","first-page":"19119","DOI":"10.1074\/jbc.M011437200","article-title":"Tyrosine-phosphorylated low density lipoprotein receptor-related protein 1 (Lrp1) associates with the adaptor protein SHC in SRC-transformed cells","volume":"276","author":"Barnes","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0055","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1128\/JVI.74.6.2777-2785.2000","article-title":"Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors","volume":"74","author":"Bartlett","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0060","doi-asserted-by":"crossref","first-page":"13079","DOI":"10.1074\/jbc.M111.229369","article-title":"Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice","volume":"286","author":"Basford","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(98)00888-X","article-title":"The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease","volume":"259","author":"Beffert","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ncb1819","article-title":"SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells","volume":"11","author":"Bell","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2011.06.002","article-title":"Inverse zonation of hepatocyte transduction with AAV vectors between mice and non-human primates","volume":"104","author":"Bell","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9000","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0085","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0090","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/01.CIR.0000163542.48611.A2","article-title":"Tissue-type plasminogen activator crosses the intact blood\u2013brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis","volume":"111","author":"Benchenane","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-2010-100180","article-title":"Statins and cognitive functioning in the elderly: a population-based study","volume":"21","author":"Benito-Leon","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0100","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0531-5565(00)00193-5","article-title":"Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies","volume":"35","author":"Bertram","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of Alzheimer disease: back to the future","volume":"68","author":"Bertram","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0110","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/bjc.2011.427","article-title":"Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1","volume":"105","author":"Bertrand","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2010.09.018","article-title":"Signaling through LRP1: protection from atherosclerosis and beyond","volume":"81","author":"Boucher","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0120","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2002-07-2081","article-title":"Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency","volume":"101","author":"Bovenschen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0125","doi-asserted-by":"crossref","first-page":"13359","DOI":"10.1074\/jbc.273.21.13359","article-title":"Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein receptor-related protein","volume":"273","author":"Bu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0130","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00003495-198937060-00002","article-title":"Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia","volume":"37","author":"Buckley","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L","article-title":"Apolipoprotein J (clusterin) and Alzheimer's disease","volume":"50","author":"Calero","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jcb.22014","article-title":"Insulin induces the low density lipoprotein receptor-related protein 1 (LRP1) degradation by the proteasomal system in J774 macrophage-derived cells","volume":"106","author":"Ceschin","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0145","first-page":"104","article-title":"LRP-1 variation is not associated with risk of Alzheimer's disease","volume":"1","author":"Chalmers","year":"2010","journal-title":"Int J Mol Epidemiol Genet"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0306-4522(03)00361-0","article-title":"The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease","volume":"121","author":"Champagne","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3177\/jnsv.52.266","article-title":"Favorable effects of tea on reducing the cognitive deficits and brain morphological changes in senescence-accelerated mice","volume":"52","author":"Chan","year":"2006","journal-title":"J Nutr Sci Vitaminol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0160","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0950-351X(96)80771-3","article-title":"Protein metabolism and liver disease","volume":"10","author":"Charlton","year":"1996","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0165","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.2025","article-title":"Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy","volume":"15","author":"Chen","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2990.2004.00614.x","article-title":"Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy","volume":"31","author":"Christoforidis","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0175","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood\u2013brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0180","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life","volume":"23","author":"Cirrito","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000319647.15752.7b","article-title":"Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study","volume":"71","author":"Cramer","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9005","doi-asserted-by":"crossref","first-page":"13049","DOI":"10.1021\/bi034752s","article-title":"All three LDL receptor homology regions of the LDL receptor-related protein bind multiple ligands","volume":"42","author":"Croy","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0190","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1524-475x.2000.00452.x","article-title":"Particle-mediated gene therapy of wounds","volume":"8","author":"Davidson","year":"2000","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0195","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.97.7.3428","article-title":"Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system","volume":"97","author":"Davidson","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0200","doi-asserted-by":"crossref","first-page":"20296","DOI":"10.1074\/jbc.M312946200","article-title":"Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid beta-protein precursor","volume":"279","author":"Davis","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood\u2013brain barrier: implication for therapies in Alzheimer's disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0215","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood\u2013brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0220","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0225","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"Multimodal RAGE-specific inhibitor reduces amyloid \u03b2-mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0235","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/01.STR.0000143452.85382.d1","article-title":"RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood\u2013brain barrier","volume":"35","author":"Deane","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","article-title":"ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo","volume":"41","author":"DeMattos","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0245","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.2008.05492.x","article-title":"Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2","volume":"106","author":"Demeule","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0250","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.107.131318","article-title":"Identification and design of peptides as a new drug delivery system for the brain","volume":"324","author":"Demeule","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0255","first-page":"3510","article-title":"Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis","volume":"109","author":"Derocq","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0260","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1515\/bc.2010.129","article-title":"Lipoprotein receptors\u2014an evolutionarily ancient multifunctional receptor family","volume":"391","author":"Dieckmann","year":"2010","journal-title":"Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer's disease: Cholesterol and beyond","volume":"12","author":"Di Paolo","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0265","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0270","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1073\/pnas.1121560109","article-title":"Extracting beta-amyloid from Alzheimer's disease","volume":"109","author":"Dries","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0275","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis","volume":"330","author":"Eisele","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0280","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1001\/jama.287.24.3223","article-title":"Dietary intake of antioxidants and risk of Alzheimer disease","volume":"287","author":"Engelhart","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0285","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1182\/blood-2003-11-4051","article-title":"Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol","volume":"103","author":"Espirito Santo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0290","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.RES.83.7.683","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins","volume":"83","author":"Essig","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/asheducation-2009.1.273","article-title":"ASH evidence-based guidelines: statins in the prevention of venous thromboembolism","author":"Evans","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3233\/JAD-2011-110662","article-title":"Extra virgin olive oil improves learning and memory in SAMP8 mice","volume":"28","author":"Farr","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0305","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","article-title":"Blood\u2013brain barrier: ageing and microvascular disease\u2014systematic review and meta-analysis","volume":"30","author":"Farrall","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0310","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0315","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/mthe.2001.0514","article-title":"Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery","volume":"5","author":"Fu","year":"2002","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0320","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.2011.07311.x","article-title":"Amyloid-beta peptide(1\u201340) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood\u2013cerebrospinal fluid barrier","volume":"118","author":"Fujiyoshi","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0325","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2012.85","article-title":"Antioxidants for Alzheimer's disease: a randomized clinical trial with cerebrospinal fluid biomarker measures","author":"Galasko","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0330","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1097\/00001756-199611040-00040","article-title":"Intra-arterial infusion of [125I]A beta 1\u201340 labels amyloid deposits in the aged primate brain in vivo","volume":"7","author":"Ghilardi","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0335","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0340","doi-asserted-by":"crossref","first-page":"25616","DOI":"10.1074\/jbc.M000955200","article-title":"Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction","volume":"275","author":"Gotthardt","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0345","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/alzrt65","article-title":"Can aerobic exercise protect against dementia?","volume":"3","author":"Graff-Radford","year":"2011","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-386509-0.00012-0","article-title":"Adeno-associated virus vectorology, manufacturing, and clinical applications","volume":"507","author":"Greieger","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0049-3848(98)00208-4","article-title":"Evolutionary conservation of circulating soluble low density lipoprotein receptor-related protein-like (\u201cLRP-like\u201d) molecules","volume":"94","author":"Grimsley","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","article-title":"Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study","volume":"80","author":"Haag","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0360","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer's disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0365","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0370","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.nbd.2006.08.006","article-title":"Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease","volume":"24","author":"Hartman","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0375","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI1500","article-title":"Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells","volume":"101","author":"Hernandez-Perera","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0380","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1750-3639.2007.00094.x","article-title":"Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice","volume":"18","author":"Herring","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0385","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0896-6273(01)00234-3","article-title":"The LDL receptor gene family: (un)expected signal transducers in the brain","volume":"29","author":"Herz","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0390","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1194\/jlr.R800077-JLR200","article-title":"Expanding functions of lipoprotein receptors","volume":"50","author":"Herz","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0395","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1002\/j.1460-2075.1988.tb03306.x","article-title":"Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor","volume":"7","author":"Herz","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0400","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200113992","article-title":"LRP: a multifunctional scavenger and signaling receptor","volume":"108","author":"Herz","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0405","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jjcc.2008.09.010","article-title":"Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease","volume":"53","author":"Hiki","year":"2009","journal-title":"J Cardiol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2009-0916","article-title":"Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration","volume":"16","author":"Ho","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0415","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.neuropharm.2009.03.001","article-title":"Downregulation of LRP1 [correction of LPR1] at the blood\u2013brain barrier in streptozotocin-induced diabetic mice","volume":"56","author":"Hong","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0420","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.nutr.19.1.141","article-title":"The mammalian low-density lipoprotein receptor family","volume":"19","author":"Hussain","year":"1999","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0425","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1021\/jf204452y","article-title":"Neuroprotective effects of citrus flavonoids","volume":"60","author":"Hwang","year":"2012","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0430","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1185\/0300799039117026","article-title":"A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial","volume":"17","author":"Illingworth","year":"2001","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0435","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/jcbfm.1992.14","article-title":"Exercise and the brain: angiogenesis in the adult rat cerebellum after vigorous physical activity and motor skill learning","volume":"12","author":"Isaacs","year":"1992","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0445","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neures.2006.07.006","article-title":"Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1\u201340) across the rat blood\u2013brain barrier","volume":"56","author":"Ito","year":"2006","journal-title":"Neurosci Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0450","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-2009-1074","article-title":"Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood\u2013brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition","volume":"17","author":"Jaeger","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0460","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1242\/jcs.058099","article-title":"Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4","volume":"123","author":"Jen","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0465","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9020","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1186\/1743-8454-3-S1-S29","article-title":"Expression of the beta-amyloid transporter, LRP-1, in aging choroid plexus: implications for the CSF-brain system in NPH and Alzheimer's disease","volume":"3","author":"Johanson","year":"2006","journal-title":"Cerebrospinal Fluid Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0470","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0475","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/WNL.49.1.56","article-title":"Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease","volume":"49","author":"Kang","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-74-1-1","article-title":"Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study","volume":"74","author":"Kannel","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0485","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.56.12.1683","article-title":"Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study","volume":"56","author":"Kivipelto","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0490","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0495","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1074\/jbc.271.11.6523","article-title":"Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and alpha 1-antitrypsin\u2013trypsin complexes is mediated by the low density lipoprotein receptor-related protein","volume":"271","author":"Kounnas","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0500","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1017\/S0007114509992364","article-title":"Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment","volume":"103","author":"Krikorian","year":"2010","journal-title":"Br J Nutr"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0505","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1021\/jf9029332","article-title":"Blueberry supplementation improves memory in older adults","volume":"58","author":"Krikorian","year":"2010","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0510","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/j.1582-4934.2008.00320.x","article-title":"C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65","volume":"12","author":"Lakshmana","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0515","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0520","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(05)78749-3","article-title":"Association at LRP gene locus with sporadic late-onset Alzheimer's disease","volume":"351","author":"Lambert","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0525","doi-asserted-by":"crossref","first-page":"e26812","DOI":"10.1371\/journal.pone.0026812","article-title":"Reversal of glial and neurovascular markers of unhealthy brain aging by exercise in middle-aged female mice","volume":"6","author":"Latimer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0530","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9025","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.300.9.1027","article-title":"Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease","volume":"300","author":"Lautenschlager","year":"2008","journal-title":"A randomized trial. JAMA"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0535","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2005.01.015","article-title":"Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice","volume":"120","author":"Lazarov","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0540","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jgm.554","article-title":"Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia","volume":"6","author":"Lebherz","year":"2004","journal-title":"J Gene Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0545","doi-asserted-by":"crossref","first-page":"23734","DOI":"10.1074\/jbc.274.34.23734","article-title":"The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein","volume":"274","author":"Lenting","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0550","doi-asserted-by":"crossref","first-page":"18000","DOI":"10.1074\/jbc.M101589200","article-title":"Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endocytosis rates","volume":"276","author":"Li","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9030","doi-asserted-by":"crossref","first-page":"432.e1","DOI":"10.1016\/j.neurobiolaging.2011.01.006","article-title":"Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model","volume":"33","author":"Lifshitz","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0555","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1152\/physrev.00033.2007","article-title":"LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies","volume":"88","author":"Lillis","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0560","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JAD-2011-110383","article-title":"Grape seed polyphenolic extract specifically decreases abeta*56 in the brains of Tg2576 mice","volume":"26","author":"Liu","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0565","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1523\/JNEUROSCI.2936-05.2005","article-title":"Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors","volume":"25","author":"Liu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0570","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-4-17","article-title":"LRP1 shedding in human brain: roles of ADAM10 and ADAM17","volume":"4","author":"Liu","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0575","doi-asserted-by":"crossref","first-page":"15499","DOI":"10.1074\/jbc.M200427200","article-title":"Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF","volume":"277","author":"Loukinova","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0580","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/jnr.21346","article-title":"Oxidative damage in mild cognitive impairment and early Alzheimer's disease","volume":"85","author":"Lovell","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archneur.60.2.203","article-title":"Antioxidant vitamin intake and risk of Alzheimer disease","volume":"60","author":"Luchsinger","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0585","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","article-title":"Circulating amyloid-beta peptide crosses the blood\u2013brain barrier in aged monkeys and contributes to Alzheimer's disease lesions","volume":"38","author":"Mackic","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0590","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1172\/JCI2029","article-title":"Human blood\u2013brain barrier receptors for Alzheimer's amyloid-beta 1\u201340. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer","volume":"102","author":"Mackic","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0595","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1471-4159.1998.70010210.x","article-title":"Cerebrovascular accumulation and increased blood\u2013brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy","volume":"70","author":"Mackic","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0600","doi-asserted-by":"crossref","first-page":"18604","DOI":"10.1074\/jbc.271.31.18604","article-title":"Role of the proposed serpin\u2013enzyme complex receptor recognition site in binding and internalization of thrombin-heparin cofactor II complexes by hepatocytes","volume":"271","author":"Maekawa","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0605","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI30889","article-title":"Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing","volume":"117","author":"Mahley","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0610","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0005-2736(85)90179-8","article-title":"Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon","volume":"819","author":"Mann","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0615","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1046\/j.1471-4159.1997.69051995.x","article-title":"Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood\u2013brain barrier transport of circulating Alzheimer's amyloid beta","volume":"69","author":"Martel","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0620","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)12462-9","article-title":"Blood\u2013brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs","volume":"206","author":"Martel","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0625","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1212\/WNL.54.6.1265","article-title":"Association of vitamin E and C supplement use with cognitive function and dementia in elderly men","volume":"54","author":"Masaki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0630","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","article-title":"Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study","volume":"75","author":"Matsuzaki","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0635","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0640","doi-asserted-by":"crossref","first-page":"18736","DOI":"10.1074\/jbc.M201979200","article-title":"Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain","volume":"277","author":"May","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0645","first-page":"CD003160","article-title":"Statins for the prevention of dementia","author":"McGuinness","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0650","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/jama.2011.810","article-title":"Changing concepts of Alzheimer disease","volume":"305","author":"McKhann","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0655","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbapap.2007.04.003","article-title":"Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIII","volume":"1774","author":"Meijer","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0660","doi-asserted-by":"crossref","first-page":"e3124","DOI":"10.1371\/journal.pone.0003124","article-title":"Changes in cognition and mortality in relation to exercise in late life: a population based study","volume":"3","author":"Middleton","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0665","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0670","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00353892","article-title":"Distribution of the alpha 2-macroglobulin receptor\/low density lipoprotein receptor-related protein in human tissues","volume":"269","author":"Moestrup","year":"1992","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0675","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1567205053585918","article-title":"LRP-mediated clearance of Abeta is inhibited by KPI-containing isoforms of APP","volume":"2","author":"Moir","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0680","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0891-5849(02)00807-9","article-title":"Lipid peroxidation in aging brain and Alzheimer's disease","volume":"33","author":"Montine","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0685","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.metabol.2010.08.013","article-title":"Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression","volume":"60","author":"Moon","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0690","first-page":"1","article-title":"The effect of rosiglitazone on LRP1 expression and amyloid beta uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment","author":"Moon","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0695","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1001\/jama.287.24.3230","article-title":"Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study","volume":"287","author":"Morris","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0700","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/461895a","article-title":"Neuroscience: Alzheimer's disease","volume":"461","author":"Mucke","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0705","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1046\/j.1471-4159.1997.69051904.x","article-title":"Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein","volume":"69","author":"Narita","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0710","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-2011-111109","article-title":"Genetic analysis of genes involved in amyloid-beta degradation and clearance in Alzheimer's disease","volume":"28","author":"Natunen","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0715","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nbd.2007.12.005","article-title":"LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood\u2013brain barrier in vitro model","volume":"30","author":"Nazer","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0720","doi-asserted-by":"crossref","first-page":"31305","DOI":"10.1074\/jbc.274.44.31305","article-title":"The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties","volume":"274","author":"Neels","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0725","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0730","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1242\/jcs.114.5.899","article-title":"Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein","volume":"114","author":"Obermoeller-McCormick","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0735","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1242\/jcs.01381","article-title":"Efficient transfer of receptor-associated protein (RAP) across the blood\u2013brain barrier","volume":"117","author":"Pan","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0740","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbr.2008.11.013","article-title":"Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity","volume":"198","author":"Papandreou","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0745","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1242\/jcs.021816","article-title":"LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein","volume":"121","author":"Parkyn","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0750","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-8-21","article-title":"Amyloid-beta transporter expression at the blood\u2013CSF barrier is age-dependent","volume":"8","author":"Pascale","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0755","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1073\/pnas.0611721104","article-title":"An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus","volume":"104","author":"Pereira","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0760","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0765","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1523\/JNEUROSCI.5451-03.2004","article-title":"FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein","volume":"24","author":"Pietrzik","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0770","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/nbdi.1997.0132","article-title":"Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1\u201340 at the blood\u2013brain barrier","volume":"4","author":"Poduslo","year":"1997","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0775","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1182\/blood-2006-08-043125","article-title":"Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit","volume":"109","author":"Polavarapu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0780","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1074\/jbc.270.6.2841","article-title":"Differential recognition of alpha 1-antitrypsin\u2013elastase and alpha 1-antichymotrypsin\u2013cathepsin G complexes by the low density lipoprotein receptor-related protein","volume":"270","author":"Poller","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0785","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1128\/JVI.76.24.12900-12907.2002","article-title":"Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands","volume":"76","author":"Ponnazhagan","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0790","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neulet.2005.03.016","article-title":"Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease","volume":"382","author":"Pritchard","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0795","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1046\/j.1471-4159.1999.0731393.x","article-title":"Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons","volume":"73","author":"Qiu","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0800","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jnen\/60.5.430","article-title":"Elevation of LDL receptor-related protein levels via ligand interactions in Alzheimer disease and in vitro","volume":"60","author":"Qiu","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0805","doi-asserted-by":"crossref","first-page":"23946","DOI":"10.1074\/jbc.272.38.23946","article-title":"Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma","volume":"272","author":"Quinn","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0810","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/excr.1999.4590","article-title":"Characterization of the soluble form of the low density lipoprotein receptor-related protein (LRP)","volume":"251","author":"Quinn","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9045","doi-asserted-by":"crossref","first-page":"40536","DOI":"10.1074\/jbc.M407592200","article-title":"Serine and threonine phosphorylation of the low density lipoprotein receptor-related protein by protein kinase Calpha regulates endocytosis and association with adaptor molecules","volume":"279","author":"Ranganathan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0815","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archneur.62.7.1047","article-title":"Statin use and the risk of incident dementia: the Cardiovascular Health Study","volume":"62","author":"Rea","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0820","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.410370212","article-title":"Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor\/low-density-lipoprotein receptor-related protein","volume":"37","author":"Rebeck","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0825","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archneurol.2011.135","article-title":"Treat Alzheimer disease before it is symptomatic","volume":"68","author":"Rosenberg","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0830","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1210\/jc.2002-012041","article-title":"Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver","volume":"87","author":"Rudling","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0835","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","article-title":"Clearance of amyloid-beta by circulating lipoprotein receptors","volume":"13","author":"Sagare","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0840","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-2010-101248","article-title":"Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-beta is an early biomarker for mild cognitive impairment preceding Alzheimer's disease","volume":"24","author":"Sagare","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0845","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jnr.22670","article-title":"From the liver to the blood\u2013brain barrier: an interconnected system regulating brain amyloid-beta levels","volume":"89","author":"Sagare","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0850","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006379","article-title":"Proteolytic degradation of amyloid \u03b2-protein","author":"Saido","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0855","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0860","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.expneurol.2011.11.036","article-title":"Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid beta peptide in mice","volume":"233","author":"Santos","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2011.07548.x","article-title":"Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins","volume":"120","author":"Schneider","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0870","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1073\/pnas.1112209109","article-title":"Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver","volume":"109","author":"Sehgal","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0875","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0880","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain's amyloid cobwebs","volume":"32","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0885","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1096\/fj.10-169508","article-title":"Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function","volume":"25","author":"Selvais","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0890","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0895","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1523\/JNEUROSCI.2236-04.2004","article-title":"Brain insulin impairs amyloid-beta(1\u201340) clearance from the brain","volume":"24","author":"Shiiki","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0900","doi-asserted-by":"crossref","first-page":"22091","DOI":"10.1074\/jbc.M110.102277","article-title":"Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance","volume":"285","author":"Shinohara","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0905","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1179\/147683009X423292","article-title":"Effects of blackberries on motor and cognitive function in aged rats","volume":"12","author":"Shukitt-Hale","year":"2009","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0910","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-101179","article-title":"Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood\u2013brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death","volume":"23","author":"Sierra","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0915","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/NEN.0b013e3181f46e25","article-title":"Amyloid efflux transporter expression at the blood\u2013brain barrier declines in normal aging","volume":"69","author":"Silverberg","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0920","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/NEN.0b013e3181c8ad2f","article-title":"Amyloid deposition and influx transporter expression at the blood\u2013brain barrier increase in normal aging","volume":"69","author":"Silverberg","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0925","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1073\/pnas.88.23.10540","article-title":"Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease","volume":"88","author":"Smith","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9040","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/156720508785132316","article-title":"Reduced risk of incident AD with elective statin use in a clinical trial cohort","volume":"5","author":"Sparks","year":"2008","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0930","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.gt.3302738","article-title":"Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells","volume":"13","author":"Stachler","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0935","doi-asserted-by":"crossref","first-page":"11772","DOI":"10.1074\/jbc.M109336200","article-title":"Interaction of CED-6\/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91\/low density lipoprotein receptor-related protein (LRP)","volume":"277","author":"Su","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0940","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1096\/fj.03-0961fje","article-title":"Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease","volume":"18","author":"Sung","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0945","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/jnr.22603","article-title":"Peripheral reduction of beta-amyloid is sufficient to reduce brain beta-amyloid: implications for Alzheimer's disease","volume":"89","author":"Sutcliffe","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0950","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(02)00664-4","article-title":"Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat","volume":"117","author":"Swain","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0955","doi-asserted-by":"crossref","first-page":"18504","DOI":"10.1074\/jbc.M410265200","article-title":"Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta)","volume":"280","author":"Takayama","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0960","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","article-title":"Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver","volume":"23","author":"Tamaki","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0965","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/mol.107.036913","article-title":"Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1 40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes","volume":"72","author":"Tamaki","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0970","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(04)00533-1","article-title":"Clearance of Alzheimer's A beta peptide: the many roads to perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0975","doi-asserted-by":"crossref","first-page":"33556","DOI":"10.1074\/jbc.273.50.33556","article-title":"Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein","volume":"273","author":"Trommsdorff","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0980","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/JNR.0b013e3182198837","article-title":"The effectiveness of exercise on improving cognitive function in older people: a systematic review","volume":"19","author":"Tseng","year":"2011","journal-title":"J Nurs Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0985","first-page":"463","article-title":"Blood\u2013brain barrier permeability precedes senile plaque formation in an Alzheimer disease model","volume":"10","author":"Ujiie","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0990","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2174\/138161211797247550","article-title":"Gene therapy for familial hypercholesterolemia","volume":"17","author":"Van Craeyveld","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb0995","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1050-1738(02)00154-8","article-title":"Phosphorylation of LRP1: regulation of transport and signal transduction","volume":"12","author":"van der Geer","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9050","article-title":"Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors","author":"Varadi","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1000","doi-asserted-by":"crossref","first-page":"17777","DOI":"10.1074\/jbc.M414248200","article-title":"The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate","volume":"280","author":"von Arnim","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1005","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000095679","article-title":"Statins of different brain penetrability differentially affect CSF PLTP activity","volume":"22","author":"Vuletic","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nbd.2008.04.006","article-title":"LRP1 modulates APP trafficking along early compartments of the secretory pathway","volume":"31","author":"Waldron","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1015","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/mt.2011.151","article-title":"AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta)","volume":"19","author":"Wang","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1020","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1096\/fj.06-6281com","article-title":"Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease","volume":"20","author":"Wang","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s004390050980","article-title":"Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease","volume":"104","author":"Wavrant-DeVrieze","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.CIR.0000109697.68832.5D","article-title":"Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors","volume":"109","author":"White","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2011.09.010","article-title":"Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease","volume":"52","author":"Williams","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1040","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1073\/pnas.92.10.4537","article-title":"Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo","volume":"92","author":"Willnow","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1045","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.7515194","article-title":"Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist","volume":"264","author":"Willnow","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1055","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-5-20","article-title":"Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease","volume":"5","author":"Wolozin","year":"2007","journal-title":"BMC Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nm1287","article-title":"Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease","volume":"11","author":"Wu","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1070","doi-asserted-by":"crossref","first-page":"34554","DOI":"10.1074\/jbc.M801487200","article-title":"The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood\u2013brain barrier cells","volume":"283","author":"Yamada","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5551\/jat.E621","article-title":"A uniqe antilipidemic drug\u2014probucol","volume":"15","author":"Yamamoto","year":"2008","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1080","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb9060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-008-0435-6","article-title":"Effects of ginko biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia","volume":"116","author":"Yan","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archneur.61.1.82","article-title":"Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study","volume":"61","author":"Zandi","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","article-title":"Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study","volume":"62","author":"Zandi","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1515\/REVNEURO.2005.16.2.123","article-title":"LRP and Alzheimer's disease","volume":"16","author":"Zerbinatti","year":"2005","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1100","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1073\/pnas.0305803101","article-title":"Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein","volume":"101","author":"Zerbinatti","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","article-title":"Microvascular injury and blood\u2013brain barrier leakage in Alzheimer's disease","volume":"28","author":"Zipser","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1110","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/0024-3205(96)00310-4","article-title":"Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood\u2013brain barrier","volume":"59","author":"Zlokovic","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1120","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00006123-199704000-00027","article-title":"Cellular and molecular neurosurgery: pathways from concept to reality\u2014part I: target disorders and concept approaches to gene therapy of the central nervous system","volume":"40","author":"Zlokovic","year":"1997","journal-title":"Neurosurgery"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1130","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1750-3639.2005.tb00103.x","article-title":"Neurovascular pathways and Alzheimer amyloid beta-peptide","volume":"15","author":"Zlokovic","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1140","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1006\/bbrc.1993.2582","article-title":"Blood\u2013brain barrier transport of circulating Alzheimer's amyloid beta","volume":"197","author":"Zlokovic","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1145","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.93.9.4229","article-title":"Glycoprotein 330\/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood\u2013brain and blood\u2013cerebrospinal fluid barriers","volume":"93","author":"Zlokovic","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(85)90963-1","article-title":"Permeability of the blood\u2013cerebrospinal fluid and blood\u2013brain barriers to thyrotropin-releasing hormone","volume":"358","author":"Zlokovic","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1155","series-title":"Program No.236.10\/F10. 2009 Neuroscience Meeting Planner","article-title":"LRP-1-cluster IV with an improved Alzheimer's A\u03b2 binding specific activity exerts an enhanced A\u03b2 sink action in mice","author":"Zlokovic","year":"2009"},{"key":"10.1016\/j.pharmthera.2012.07.008_bb1160","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/77397","article-title":"Clearance of amyloid beta-peptide from brain: transport or metabolism?","volume":"6","author":"Zlokovic","year":"2000","journal-title":"Nat Med"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T11:44:00Z","timestamp":1642851840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":240,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0163725812001337"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.008","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}